Lee, Jae Cheol, Jen-Yu Hung, Young-Chul Kim, Gee-Chen Chang, Seung Yoo, Sheng-Hsiung Yang, Keith Davis, Saurabh Nagar, Aliki Taylor, Sung Lee, and Jin-Yuan Shih. 2021. “Real-World Treatment Patterns in Patients With EGFR Mutation-Positive NSCLC Receiving a First-Line, First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in South Korea and Taiwan”. Asian Pacific Journal of Cancer Biology 6 (2), 123-32. https://doi.org/10.31557/apjcb.2021.6.2.123-132.